Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goldin
J M Venditti

Showing results (1-10 of 235) with videos related to

Pageof 24
Sort By:
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
A prospective screening program: current screening and its statusA Goldin, J M Venditti
Cancer Treatment Reviews|December 1, 1980
Progress report on the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The new NCI screen and its implications for clinical evaluationA Goldin, J M Venditti
Investigational New Drugs|January 1, 1985
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a reviewA Goldin, J M Venditti, R Geran
National Cancer Institute Monograph|March 1, 1977
Screening at the National Cancer InstituteA Goldin, J M Venditti, S K Carter
Antibiotics and Chemotherapy|January 1, 1980
Usefulness and limitations of murine tumor models for the identification of new antitumor agentsA Goldin, R K Johnson, J M Venditti
Nature|November 26, 2010
Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factorA Goldin, J M Venditti, I Kline, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1978
Search for new radiation potentiatorsA Goldin, I Wodinsky, P C Merker, et al.
European Journal of Cancer|September 1, 1978
Circadian dependence of host and tumor responses to cyclophosphamide in miceS S Cardoso, T Avery, J M Venditti, et al.
Cancer Chemotherapy Reports. Part 2|November 1, 1972
Methanesulfonates: the relationship of structure to antitumor activityJ S Sandberg, H B Wood, R R Engle, et al.
Pageof 24

Showing results (1-10 of 235) with videos related to

Sort By:
Pageof 24
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
A prospective screening program: current screening and its statusA Goldin, J M Venditti
Cancer Treatment Reviews|December 1, 1980
Progress report on the screening program at the Division of Cancer Treatment, National Cancer InstituteA Goldin, J M Venditti
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The new NCI screen and its implications for clinical evaluationA Goldin, J M Venditti
Investigational New Drugs|January 1, 1985
The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a reviewA Goldin, J M Venditti, R Geran
National Cancer Institute Monograph|March 1, 1977
Screening at the National Cancer InstituteA Goldin, J M Venditti, S K Carter
Antibiotics and Chemotherapy|January 1, 1980
Usefulness and limitations of murine tumor models for the identification of new antitumor agentsA Goldin, R K Johnson, J M Venditti
Nature|November 26, 2010
Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factorA Goldin, J M Venditti, I Kline, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 1978
Search for new radiation potentiatorsA Goldin, I Wodinsky, P C Merker, et al.
European Journal of Cancer|September 1, 1978
Circadian dependence of host and tumor responses to cyclophosphamide in miceS S Cardoso, T Avery, J M Venditti, et al.
Cancer Chemotherapy Reports. Part 2|November 1, 1972
Methanesulfonates: the relationship of structure to antitumor activityJ S Sandberg, H B Wood, R R Engle, et al.
Pageof 24